ArticleThe Lancet regional health. Southeast Asia2026
Determinants of small vulnerable newborn births in two rural community-based cohorts in India: a prospective study.
Article in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Small Vulnerable Newborn (SVN) Consortium introduced the concept of SVN, combining preterm, low birth weight (LBW), and small for gestational age (SGA) into a single category. Limited data on the actual SVN burden and its determinants formed the basis of this study, where we estimated its incidence and associated factors in two distinct pregnant women cohorts in India. Methods: The study followed pregnant women cohorts from Hodal, Haryana, and Lowairpoa, Assam, through their antenatal period until 12 months postpartum to identify adverse maternal and infant outcomes. Incidence of SVN was estimated, and its association with various factors was assessed using modified Poisson regression models. Findings: The overall incidence of SVN was 48.3%, with term-SGA, preterm non-SGA, and preterm-SGA accounting for 32.2%, 14.7%, and 2.9%, respectively. This pattern was consistent across both sites. SVN incidence was higher among multiple gestations than among singleton births. Significant risk factors included antepartum hemorrhage [Hodal (H): adjusted relative risk [aRR] 1.29; 95% confidence interval [CI]: 1.15-1.44; Lowairpoa (L): aRR 1.88; 95% CI: 1.58-2.24], maternal height <145 cm [H: 1.30 (1.21-1.39); L: 1.24 (1.12-1.37)], previous LBW history [H: 1.33; 1.25-1.42; L: 1.47; 1.23-1.76], nulliparity [H: 1.31; 1.23-1.38; L: 1.39; 1.24-1.55], and exclusive biomass-fuel use [H: 1.13; 1.06-1.20; L: 1.26; 1.09-1.46]. Interpretation: This study suggests the need for targeted region-specific antenatal interventions to address the burden of small vulnerable newborns. Funding: This study was funded by The Gates Foundation to GK (INV-002320).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.